DossierENTITY

cell and gene therapy

Coverage of cell and gene therapy in the Nexus archive.

Earliest in view: Jun 26 · 14:20 UTCMost recent: Jun 26 · 14:20 UTC

Co-mentioned in this coverage

Recent coverage

BUSINESSJun 26 · 14:20 UTCQUARTZ
Germany's Merck KGaA is buying lab-tools supplier Bio-Techne for $11.3 billion
Germany's Merck KGaA is acquiring lab-tools supplier Bio-Techne for $11.3 billion, marking its largest deal since the Sigma-Aldrich buyout. The acquisition expands Merck's presence in proteins, spatial biology, and cell and gene therapy.